The Relationship Between FAPI Results and Myocardial Fibrosis After Acute Myocardial Infarction

NCT06841549 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2025-02-24

No results posted yet for this study

Summary

FAPI is a new method to discover the fibrosis of cardiac myocardium in some conditions, like myocardial infarction or cardiomyopathy. This purpose of this study is to find the relationship between FAPI results and myocardial fibrosis through some clinical serum inflammatory factors level. Meanwhile, it is the first time to provide the prognostic value of FAPI in the progression of acute myocardial infarction.

Conditions

  • Acute Myocardial Infarction (AMI)

Interventions

OTHER

FAPI

FAPI is a new method to find the myocardial fibrosis under some conditions, like myocardial infarction or cardiac myopathy.

Sponsors & Collaborators

  • The First Affiliated Hospital of Xiamen University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-03
Primary Completion
2025-01-20
Completion
2025-01-25

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06841549 on ClinicalTrials.gov